Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15684 | 28761689 | BMJ Open Gastroenterol | Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. | 2017 | Details |
| A15698 | 28753963 | Nutrients | The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats. | 2017 | Details |
| A15707 | 28751080 | Med Clin (Barc) | Non-alcoholic fatty liver disease: A poorly known pandemic. | 2017 | Details |
| A15736 | 28737568 | J Pediatr Gastroenterol Nutr | Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15738 | 28735109 | Contemp Clin Trials | Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. | 2017 | Details |
| A15775 | 28715286 | Scand J Clin Lab Invest | Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15776 | 28714900 | Int J Mol Sci | A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15777 | 28714405 | Curr Pharm Des | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | 2017 | Details |
| A15811 | 28698350 | BMJ Open | Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. | 2017 | Details |
| A15820 | 28694246 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2017 | Details |
| A15835 | 28689548 | Ugeskr Laeger | [Non-alcoholic fatty liver disease in children and adolescents]. | 2017 | Details |
| A15837 | 28688543 | Eur J Intern Med | Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer? | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15862 | 28677333 | Aliment Pharmacol Ther | Review article: new treatments in non-alcoholic fatty liver disease. | 2017 | Details |
| A15870 | 28676332 | Respir Physiol Neurobiol | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. | 2017 | Details |
| A15872 | 28676026 | Curr Vasc Pharmacol | A Critical Approach of Guideline Therapeutic Recommendations for NAFLD. | 2018 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15924 | 28650209 | Expert Rev Gastroenterol Hepatol | The intestinal barrier: a fundamental role in health and disease. | 2017 | Details |
| A15934 | 28645738 | J Hepatol | Human germline hedgehog pathway mutations predispose to fatty liver. | 2017 | Details |
| A15940 | 28642059 | J Hepatol | New trends on obesity and NAFLD in Asia. | 2017 | Details |
| A15958 | 28637408 | Curr Vasc Pharmacol | Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis. | 2018 | Details |
| A16001 | 28619255 | J Hepatol | Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. | 2017 | Details |
| A16022 | 28606220 | Nutr Res Rev | Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer. | 2017 | Details |
| A16024 | 28605159 | Obesity (Silver Spring) | Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity. | 2017 | Details |
| A16030 | 28600319 | Physiol Genomics | Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification. | 2017 | Details |
| A16033 | 28599248 | Biomed Pharmacother | The multifaceted role of natriuretic peptides in metabolic syndrome. | 2017 | Details |
| A16039 | 28596817 | World J Hepatol | Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. | 2017 | Details |
| A16051 | 28593739 | Hepatol Res | Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
| A16054 | 28592311 | Trials | The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. | 2017 | Details |
| A16057 | 28591070 | J Clin Gastroenterol | Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). | 2017 | Details |
| A16063 | 28587078 | Nutrients | Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction. | 2017 | Details |
| A16075 | 28584294 | Sci Rep | Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver. | 2017 | Details |
| A16078 | 28581252 | Liver Int | NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1 H-MRS? | 2017 | Details |
| A16093 | 28574988 | PLoS One | The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study. | 2017 | Details |
| A16132 | 28545937 | J Hepatol | Treatment of NAFLD with diet, physical activity and exercise. | 2017 | Details |
| A16134 | 28545368 | Curr Med Chem | Improving Metabolic Control Through Functional Foods. | 2019 | Details |
| A16135 | 28544769 | Liver Int | Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH. | 2017 | Details |
| A16157 | 28533672 | World J Gastroenterol | Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. | 2017 | Details |
| A16190 | 28511163 | Wiad Lek | [Impact of physical activity on anthropometric indices in patients with nonalcoholic fatty liver disease and pre-diabetes or type 2 diabetes]. | 2017 | Details |
| A16193 | 28511023 | Appl Physiol Nutr Metab | Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial. | 2017 | Details |
| A16209 | 28506362 | Gastroenterol Clin North Am | Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16216 | 28503750 | Diabetes Obes Metab | Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. | 2017 | Details |
| A16256 | 28482789 | Curr Med Chem | Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver. | 2019 | Details |
| A16280 | 28471945 | AIDS | Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver. | 2017 | Details |
| A16283 | 28471823 | Eur J Gastroenterol Hepatol | The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review. | 2017 | Details |
| A16321 | 28460349 | Cancer Epidemiol | Nonalcoholic fatty liver disease and mortality among cancer survivors. | 2017 | Details |
| A16331 | 28455679 | Curr Obes Rep | Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. | 2017 | Details |
| A16334 | 28452727 | Georgian Med News | [THE INFLUENCE OF LIFESTYLE ON BIOMARKERS OF FIBROSIS IN PATIENTS WITH STABLE CORONARY HEART DISEASE ON THE BACKGROUND OF NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2017 | Details |
| A16433 | 28392404 | Prog Lipid Res | A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. | 2017 | Details |
| A16438 | 28388904 | BMC Complement Altern Med | Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study. | 2017 | Details |
| A16463 | 28373762 | World J Gastroenterol | Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. | 2017 | Details |
| A16466 | 28371239 | Liver Int | The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. | 2017 | Details |
| A16495 | 28356106 | Lipids Health Dis | Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice. | 2017 | Details |
| A16506 | 28348495 | World J Gastroenterol | Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients. | 2017 | Details |
| A16517 | 28345499 | Br J Nutr | Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. | 2017 | Details |
| A16531 | 28333768 | J Pediatr Gastroenterol Nutr | Management of Pediatric Nonalcoholic Fatty Liver Disease by Academic Hepatologists in Canada: A Nationwide Survey. | 2017 | Details |
| A16532 | 28332619 | Sci Rep | Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study. | 2017 | Details |
| A16571 | 28299304 | Adv Biomed Res | Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16572 | 28299034 | Int J Prev Med | The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients. | 2017 | Details |
| A16583 | 28297798 | Zhonghua Gan Zang Bing Za Zhi | [Treatment of non-alcoholic fatty liver disease: an interpretation of the European clinical guidelines for obesity, type 2 diabetes, and digestive disease]. | 2017 | Details |
| A16624 | 28277977 | Epigenetics | Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action. | 2017 | Details |
| A16627 | 28276821 | Expert Rev Gastroenterol Hepatol | Current and future treatment options in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A16628 | 28276774 | Expert Rev Clin Pharmacol | Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A16633 | 28273805 | Nutrients | Fructose and NAFLD: The Multifaceted Aspects of  Fructose Metabolism. | 2017 | Details |
| A16724 | 28222828 | Nutr Res Rev | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. | 2017 | Details |
| A16738 | 28215516 | Dig Liver Dis | AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. | 2017 | Details |
| A16753 | 28209193 | BMC Complement Altern Med | UP601, a standardized botanical composition composed of Morus alba, Yerba mate and Magnolia officinalis for weight loss. | 2017 | Details |
| A16761 | 28195363 | Hepatology | Liver fibrosis scores predict liver disease mortality in the United States population. | 2017 | Details |
| A16777 | 28183444 | Metabolism | Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. | 2016 | Details |
| A16783 | 28179090 | Dig Liver Dis | Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16813 | 28158893 | Drug Res (Stuttg) | Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2017 | Details |
| A16824 | 28148637 | J Pharmacol Exp Ther | Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice. | 2017 | Details |
| A16826 | 28144390 | World J Hepatol | Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. | 2017 | Details |
| A16839 | 28133993 | Appl Physiol Nutr Metab | A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A16884 | 28111263 | Pharmacol Res | An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. | 2017 | Details |
| A16903 | 28103626 | Hepatology | Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. | 2017 | Details |
| A16925 | 28089623 | Dig Liver Dis | Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | 2016 | Details |
| A16926 | 28089502 | Diabetes Metab | An extended fatty liver index to predict non-alcoholic fatty liver disease. | 2017 | Details |
| A16935 | 28084795 | Appl Physiol Nutr Metab | Moderate physical activity promotes basal hepatic autophagy in diet-induced obese mice. | 2016 | Details |
| A16992 | 28058253 | Can J Gastroenterol Hepatol | More Frequent Clinic Visits Are Associated with Improved Outcomes for Children with NAFLD. | 2016 | Details |
| A17002 | 28052636 | Liver Int | Non-pharmacological interventions in non-alcoholic fatty liver disease patients. | 2017 | Details |
| A17004 | 28052626 | Liver Int | Therapies in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A17010 | 28051263 | Eur Rev Med Pharmacol Sci | Psychological factors associated with NAFLD/NASH: a systematic review. | 2016 | Details |
| A17050 | 28028356 | World J Gastroenterol | Sirtuins and nonalcoholic fatty liver disease. | 2016 | Details |
| A17060 | 28017576 | Prim Care Diabetes | Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients. | 2016 | Details |
| A17081 | 28001263 | Rev Assoc Med Bras (1992) | Current management of non-alcoholic fatty liver disease. | 2016 | Details |
| A17096 | 27995280 | Arch Toxicol | Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A17100 | 27992361 | J Pediatr Endocrinol Metab | Risk factors that affect metabolic health status in obese children. | 2017 | Details |
| A17129 | 27976635 | Saudi J Gastroenterol | Outcome of phlebotomy for treating nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A17148 | 27957244 | World J Hepatol | Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. | 2016 | Details |
| A17159 | 27941355 | Curr Opin Infect Dis | Managing nonalcoholic fatty liver disease in patients living with HIV. | 2017 | Details |
| A17202 | 27916647 | Biochimie | PPARs and nonalcoholic fatty liver disease. | 2016 | Details |
| A17209 | 27913605 | Eur J Endocrinol | Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. | 2017 | Details |
| A17222 | 27905898 | BMC Med Genet | Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population. | 2016 | Details |
| A17223 | 27904677 | Am J Transl Res | An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function. | 2016 | Details |
| A17239 | 27895389 | J Clin Biochem Nutr | Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
| A17247 | 27890486 | Clin Nutr | Towards a multidisciplinary approach to understand and manage obesity and related diseases. | 2016 | Details |
| A17265 | 27880977 | Hepatology | Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. | 2017 | Details |
| A17272 | 27872651 | Evid Based Complement Alternat Med | A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease. | 2016 | Details |